Adjunctive rifampicin to reduce early mortality from <it>Staphylococcus aureus</it> bacteraemia (ARREST): study protocol for a randomised controlled trial

<p>Abstract</p> <p>Background</p> <p><it>Staphylococcus aureus</it> bacteraemia is a common and serious infection, with an associated mortality of ~25%. Once in the blood, <it>S. aureus</it> can disseminate to infect almost any organ, but bones, joints and heart valves are most frequently affected....

وصف كامل

التفاصيل البيبلوغرافية

المؤلفون الرئيسيون:	Thwaites Guy, Auckland Cressida, Barlow Gavin, Cunningham Richard, Davies Gerry, Edgeworth Jonathan, Greig Julia, Hopkins Susan, Jeyaratnam Dakshika, Jenkins Neil, Llewelyn Martin, Meisner Sarah, Nsutebu Emmanuel, Planche Tim, Read Robert C, Scarborough Matthew, Soares Marta, Tilley Robert, Török M Estée, Williams John, Wilson Peter, Wyllie Sarah, Walker A Sarah
التنسيق:	Artigo
اللغة:	Inglês
منشور في:	BMC 2012-12-01
سلاسل:	Trials
الموضوعات:	<it>Staphylococcus aureus</it> Bacteraemia Rifampicin Mortality
الوصول للمادة أونلاين:	http://www.trialsjournal.com/content/13/1/241
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!